Cited by 394Ferroptosis and cancer prognosisCell death mechanisms and regulationIron Metabolism and Disorders

Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells

Ooko, Edna, Saeed, Mohamed E.M., Kadioglu, Onat, Sarvi, Shabnam, Colak, Merve, Elmasaoudi, Kaoutar, Janah, Rabab, Greten, Henry J. +1 more·2015·Phytomedicine

Abstract

Background Apoptosis and other forms of cell death have been intensively investigated in the past years to explain the mode of action of synthetic anticancer drugs and natural products. Recently, a new form of cell death emerged, which was termed ferroptosis, because it depends on intracellular iron. Here, the role of genes involved in iron metabolism and homeostasis for the cytotoxicity of ten artemisinin derivatives have been systematically investigated.Material and methods Log10IC50 values of 10 artemisinin derivatives (artesunate, artemether, arteether, artenimol, artemisitene, arteanuin B, another monomeric artemisinin derivative and three artemisinin dimer molecules) were correlated to the microarray-based mRNA expression of 30 iron-related genes in 60 cell lines of the National Cancer Institute (NCI, USA) as determined in 218 different microarray hybridization experiments. The effect of desferoxamine and ferrostatin-1 on the cytotoxicity of artenimol of CCRF-CEM cells was determined by resazurin assays. The mRNA expression of TFRC was exemplarily validated by immunohistochemical detection of transferrin receptor protein expression.Results The mRNA expression of 20 genes represented by 59 different cDNA clones significantly correlated to the log10IC50 values for the artemisinins, including genes encoding transferrin (TF), transferrin receptors 1 and 2 (TFRC, TFR2), cerulopasmin (CP), lactoferrin (LTF) and others. The ferroptosis inhibitor ferrostatin-1 and the iron chelator deferoxamine led to a significantly reduced cytotoxicity of artenimol, indicating ferroptosis as cell death mode.Conclusion The numerous iron-related genes, whose expression correlated with the response to artemisinin derivatives speak in factor for the relevance of iron for the cytotoxic activity of these compounds. Treatment with ferroptosis-inducing agents such as artemisinin derivatives represents an attractive strategy for cancer therapy. Pre-therapeutic determination of iron-related genes may indicate tumor sensitivity to artemisinins. Ferroptosis induced by artemisinin-type drugs deserve further investigation for individualized tumor therapy.

Integrity signals

Registry

Crossref · 10.1016/j.phymed.2015.08.002

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Artemisinin derivatives induce iron-dependent cell death, specifically ferroptosis.

    “Of note, artemisinin derivatives have been reported to induce iron-dependent cell death, and specifically ferroptosis”

    From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [84]

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ooko, E., Saeed, M. E. M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H. J., & Efferth, T.
Affiliations
  • Johannes Gutenberg University Mainz (DE)
  • Universidade do Porto (PT)
Corresponding author
Efferth, Thomas
Venue
Phytomedicine
Publisher
Elsevier BV
Published
2015-10
Volume
22
Issue
11
Pages
1045-1054
ISSN
0944-7113 (ISSN-L)
OpenAlex
W1156477804
Cited by
387
References
54
Citations by year
2026: 23 · 2025: 32 · 2024: 37 · 2023: 48 · 2022: 60 · 2021: 57 · 2020: 46 · 2019: 27 · 2018: 23 · 2017: 14 · 2016: 16 · 2015: 3
FWCI
14.78
Type
journal article
Language
en
Open access
closed
Locations
  • Phytomedicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords
artemisinin derivatives, ferroptosis, iron metabolism, ferrostatin-1, deferoxamine, transferrin receptor, ceruloplasmin, lactoferrin, tumor cell killing, anticancer natural products, CCRF-CEM cells, precision oncology
MeSH terms
Artesunate, Artemether, Cyclohexylamines, Deferoxamine, Humans, Iron, Phenylenediamines, Molecular Structure, Gene Expression Regulation, Neoplastic, Cell Death, Apoptosis, Inhibitory Concentration 50, Oligonucleotide Array Sequence Analysis, Artemisinins, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review